EE139 Intensification with Insulin Glargine 300 U/Ml (Gla-300) or First- Generation Basal Insulins (BIs) in People with Type 2 Diabetes (T2D) on Once-Weekly Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): Deliver New-G
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.438
https://www.valueinhealthjournal.com/article/S1098-3015(24)00553-9/fulltext
Section Title :
Section Order :
11785
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00553-9&doi=10.1016/j.jval.2024.03.438